Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Chuanying Geng"'
Autor:
Yuan Jian, Feifei Han, Ying Zhu, Chuanying Geng, Yanru Zhang, Yin Wu, Yun Leng, Wenming Chen, Zhuoling An, Hong‐Hu Zhu
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 9, Pp n/a-n/a (2024)
Abstract Venetoclax, a small molecule inhibitor of BCL‐2, has demonstrated efficacy in treating acute leukemias and has been recommended as one of the first‐line anti‐leukemia therapies. Although venetoclax has been suggested to probably posses
Externí odkaz:
https://doaj.org/article/beaed3f7af654f108164236d6ccf5267
Autor:
Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Wenming Chen
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective To evaluate the prognostic value of t(4; 14) translocation for newly diagnosed multiple myeloma (MM) patients in the novel agent era.Methods We retrospectively analyzed 606 newly diagnosed MM patients treated with novel agents. The
Externí odkaz:
https://doaj.org/article/77c6695c960b49daad476f0f93ac9dc0
Autor:
Chuanying Geng, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Guangzhong Yang, Wenming Chen
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Several studies showed that lack of CD56 expression was a poor prognostic factor for patients with newly diagnosed multiple myeloma (NDMM). However, other studies were not able to confirm the prognostic value of CD56 in NDMM. This
Externí odkaz:
https://doaj.org/article/788b438556cf465983a963900bdc7f3b
Autor:
Yuan Jian, Huixing Zhou, Yidan Wang, Zhiyao Zhang, Guangzhong Yang, Chuanying Geng, Ying Tian, Wen Gao, Wenming Chen
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4182-4192 (2022)
Abstract Background Pulmonary hypertension (PH) is a common but rarely recognized comorbidity of multiple myeloma (MM) patients, while its prognostic significance for MM has been rarely reported. Methods We retrospectively analyzed the clinical chara
Externí odkaz:
https://doaj.org/article/e7cb81a0ec6f4cbfb6c939b13d2a939b
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesVenous thromboembolism (VTE) is a common complication among patients with newly diagnosed multiple myeloma (NDMM). Therefore, this study aimed to analyze the incidence and risk factors associated with VTE in the current era of thromboprophy
Externí odkaz:
https://doaj.org/article/dde6741b2d924994b4f49e11ea39f020
Autor:
Yuan Jian, Zhiyao Zhang, Huixing Zhou, Guangzhong Yang, Chuanying Geng, Huijuan Wang, Wen Gao, Wenming Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTranslocation (11;14) is one of the most frequent recurrent cytogenetic abnormalities in multiple myeloma (MM), while its clinical prognostic value remains controversial. CD20 expression is uncommon in MM while strongly associated with t(11;
Externí odkaz:
https://doaj.org/article/cbac385234f34d92bb4413d5f42356f8
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 2, Pp 91-97 (2020)
Objective: The management experience for plasma cell leukemia (PCL) is still limited by PCL's rare incidence and aggressive course. The goal of this study was to further identify the efficacy of bortezomibcontaining regimens for PCL in Chinese patien
Externí odkaz:
https://doaj.org/article/4b7f18a4dae44781a63e0946632d5250
Publikováno v:
Advances in Therapy. 39:3799-3834
The combination of lenalidomide, bortezomib, and dexamethasone (RVd) has become standard of care for transplant-eligible patients with newly diagnosed MM (NDMM). This study aimed to determine the efficacy of RVd as induction therapy in terms of respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6af8f62d478f3771991d00e37194fe
https://doi.org/10.1007/s12325-022-02195-1
https://doi.org/10.1007/s12325-022-02195-1
Autor:
Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Wenming Chen
Publikováno v:
Clinical and Experimental Medicine.
Background: The basic activities of daily life may affect the prognosis of multiple myeloma (MM) patients and the Barthel index (BI) is currently the most widely used tool to evaluate basic activities of daily life, but few studies have evaluated its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19774611657679fb50cadb848b269757
https://doi.org/10.1007/s10238-023-01002-7
https://doi.org/10.1007/s10238-023-01002-7
Publikováno v:
Leukemia & Lymphoma. 62:2992-3001
We retrospectively studied the impact of cytogenetic abnormalities in 328 consecutive newly diagnosed multiple myeloma (MM) patients. High-risk cytogenetic abnormalities (HRCAs) included del (17p), amp/gain (1q21), t(4;14), and t(14;16). We defined a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f86a4fc38c009d3dd7ce442fe39b696
https://doi.org/10.1080/10428194.2021.1948032
https://doi.org/10.1080/10428194.2021.1948032